SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020622
Filing Date
2024-02-27
Accepted
2024-02-27 07:22:28
Documents
113
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K beam-20231231.htm   iXBRL 10-K 4012618
2 EX-10.29 beam-ex10_29.htm EX-10.29 18498
3 EX-10.39 beam-ex10_39.htm EX-10.39 32412
4 EX-10.40 beam-ex10_40.htm EX-10.40 40152
5 EX-10.41 beam-ex10_41.htm EX-10.41 34509
6 EX-23.1 beam-ex23_1.htm EX-23.1 3908
7 EX-31.1 beam-ex31_1.htm EX-31.1 28895
8 EX-31.2 beam-ex31_2.htm EX-31.2 28854
9 EX-32.1 beam-ex32_1.htm EX-32.1 8368
10 EX-32.2 beam-ex32_2.htm EX-32.2 9349
11 EX-97.1 beam-ex97_1.htm EX-97.1 30568
12 GRAPHIC img43059740_0.jpg GRAPHIC 471468
13 GRAPHIC img43059740_1.jpg GRAPHIC 353123
14 GRAPHIC img55914526_0.jpg GRAPHIC 631
  Complete submission text file 0000950170-24-020622.txt   17475784

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20231231.xsd EX-101.SCH 2296104
115 EXTRACTED XBRL INSTANCE DOCUMENT beam-20231231_htm.xml XML 2738224
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39208 | Film No.: 24681972
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)